Shuttle Pharmaceuticals Receives Nasdaq Notice for Missing Quarterly Filing Deadline
Shuttle Pharmaceuticals (SHPH) has received a notice from Nasdaq regarding non-compliance due to its failure to file the Q2 2026 Form 10-Q by the required deadline. The company announced on Friday that it intends to submit the report as soon as possible. The delay in filing raises concerns about Shuttle Pharmaceuticals' internal controls and financial reporting processes, which could affect investor confidence. Nasdaq typically allows a short grace period for such filings before taking further action, including potential delisting proceedings if compliance is not achieved within the specified timeframe.
